Hims & Hers HealthHIMS

A securities class action lawsuit has been filed against Hims & Hers following a federal complaint from the FTC, a government agency that protects consumers from unfair business practices. The FTC is accusing the company of business misconduct, though the specific details of the allegations have not been fully disclosed in this filing.

Lawsuits like this are common after a stock price drops on regulatory news, as they aim to recover losses for shareholders by claiming the company misled them. While these cases often take years to resolve and are frequently settled, the underlying FTC investigation is the more serious concern. If the government finds that Hims & Hers used deceptive practices to sign up or keep subscribers, it could force expensive changes to how the company grows its business.

A group of investors has filed a lawsuit against Hims & Hers and its leaders. The suit follows a complaint from the Federal Trade Commission (FTC), a government agency that protects consumers, which accused the company of misconduct in how it runs its business.

Lawsuits like this are common after a federal investigation or a sharp drop in stock price. While they can take years to resolve and often end in settlements, the underlying FTC investigation is the more serious concern. It could force the company to change how it signs up or bills its 2.2 million subscribers, which is the core of its business model.

Source: PRNewsWire

The FDA warned telehealth companies and compounding pharmacies, businesses that mix their own versions of drugs, about selling unapproved weight-loss treatments. Specifically, the agency noted that newer drugs like retatrutide cannot legally be used in these custom mixes. This is a reminder that the regulatory rules for these pharmacies are strict and can change as new drugs hit the market.

This matters because a large part of the growth for Hims & Hers now comes from selling these custom, lower-cost versions of popular weight-loss shots. While the company has built its business on following these rules, any sign that regulators are tightening the leash on what can be made and sold is a risk to its newest and fastest-growing business line.

Source: Proactive Investors

Hims & Hers has officially started serving customers in Australia. This is the company's first move into the Asia-Pacific region and follows its purchase of Eucalyptus, a local health firm, earlier this year. The rollout begins with rebranding Pilot, a men's health platform, under the Hims name.

This is a logical step for growth. By using an existing business as a foundation, the company can expand its subscriber base outside of the U.S. without starting from zero. Success here will depend on whether the brand's personalized approach to treatments like hair loss and sexual health translates well to the Australian market.

Source: Business Wire

Hagens Berman, a firm that represents shareholders, has opened an investigation into the company's compliance and business practices. This follows a lawsuit from the Federal Trade Commission (FTC), a government agency that protects consumers, which alleged the company used improper billing and privacy practices.

While law firm investigations are common after a stock price drop, the underlying FTC lawsuit is a real concern. If the government proves the company made it too hard to cancel subscriptions or handled patient data poorly, it could lead to fines or forced changes to how the company signs up new customers.

Source: PRNewsWire

Metrics we are tracking